Vascular endothelial growth factor expression in early stage ovarian carcinoma
暂无分享,去创建一个
L. Twiggs | P. Paley | S. Ramakrishnan | L. Carson | K. Gebhard | K. Staskus | Kristin Gebhard | Pamela J. Paley | Katherine A. Staskus | Dhanabal Mohanraj | Leo B. Twiggs | Linda F. Carson | Sundaram Ramakrishnan | D. Mohanraj
[1] H. Dvorak,et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.
[2] H. Dvorak,et al. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. , 1995, Cancer research.
[3] Friedland Ml,et al. Prognostic factors in ovarian cancer. , 1991 .
[4] A. Haase,et al. Detection of Viral Nucleic Acids by in Situ Hybridization , 1984 .
[5] Bing Li,et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.
[6] W Blumenfeld,et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. , 1993, The American journal of pathology.
[7] P. Wingo,et al. Cancer statistics, 1995 , 1995, CA: a cancer journal for clinicians.
[8] R. Bast,et al. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. , 1990, Cancer research.
[9] V. Beral,et al. Risk factors for ovarian cancer: a case-control study. , 1989, British Journal of Cancer.
[10] E. Manseau,et al. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. , 1995, American Journal of Pathology.
[11] J. Folkman. What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.
[12] J. Niloff,et al. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[13] D. Gonzalez-Dunia,et al. Simultaneous in situ detection of two mRNAs in the same cell using riboprobes labeled with biotin and 35S. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[14] G. Sledge,et al. Neovascularization in clinical stage A testicular germ cell tumor: prediction of metastatic disease. , 1994, Cancer research.
[15] P. Humphrey,et al. Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. , 1993, Obstetrics and gynecology.
[16] L. Ellis,et al. The implications of angiogenesis for the biology and therapy of cancer metastasis , 1994, Cell.
[17] L. Lagasse,et al. The role of adjuvant therapy in Stage I ovarian cancer. , 1980, American journal of obstetrics and gynecology.
[18] S. Ellenberg,et al. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials , 1990, The New England journal of medicine.
[19] S. Ramakrishnan,et al. Vascular permeability factor gene expression in normal and neoplastic human ovaries. , 1994, Cancer research.
[20] L. Liotta,et al. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.
[21] D. Charnock-Jones,et al. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. , 1995, Journal of the National Cancer Institute.
[22] F Pozza,et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.
[23] Y. Chung,et al. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] D. Mohanraj,et al. In vivo neutralization of vascular endothelial growth factor (VEGF) vascular permeability factor (VPF) inhibits ovarian carcinoma-associated ascites formation and tumor growth. , 1996, International journal of oncology.
[25] G. Fleuren,et al. DNA index reflects the biological behavior of ovarian carcinoma stage I-IIa. , 1996, Gynecologic Oncology.
[26] D. Connolly,et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. , 1989, The Journal of clinical investigation.
[27] J. Folkman,et al. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.
[28] C. Angeletti,et al. Relation of neovascularisation to metastasis of non-small-cell lung cancer , 1992, The Lancet.
[29] A. Stenwig,et al. Prognostic Factors in Patients With Stage I Epithelial Ovarian Cancer , 1990, Obstetrics and gynecology.